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Abstract
AIM: To compare the effects of neurolytic celiac plexus
block (NCPB) and videothoracoscopic splanchnicectomy
(VSPL) on pain and quality of life of chronic pancreatitis
(CP) patients.
METHODS: Forty-eight small duct CP patients were
treated invasively with NCPB (n = 30) or VSPL (n = 18) in
two non-randomized, prospective, case-controlled protocols
due to chronic pain syndrome, and compared to a control
group who were treated conservatively (n = 32). Visual analog
scales were used to assess pain and opioid consumption
rate was evaluated. In addition, the quality of life was
measured using QLQ C-30 for NCPB and FACIT for VSPL.
Although both questionnaires covered similar problems,
they could not be compared directly one with another.
Therefore, the studies were compared by meta-analysis
methodology.
RESULTS: Both procedures resulted in a significant positive
effect on pain of CP patients. Opioids were withdrawn
totally in 47.0% of NCPB and 36.4% of VSPL patients,
and reduced in 53.0% and 45.4% of the respective patient
groups. No reduction in opioid usage was observed in the
control group. In addition, fatigue and emotional well-being
showed improvements. Finally, NCPB demonstrated stronger
positive effects on social support, which might possibly
be attributed to earlier presentation of patients treated
with NCPB.
CONCLUSION: Both invasive pain treatment methods are
effective in CP patients with chronic pain.
© 2005 The WJG Press and Elsevier Inc. All rights reserved.
Key words: Chronic pancreatitis; Pain; Neurolytic celiac
plexus block; Videothoracoscopic splanchnicectomy; Quality
of life
Basinski A, Stefaniak T, Vingerhoets A, Makarewicz W, Kaska
L, Stanek A, Lachinski AJ, Sledzinski Z. Effect of NCPB and
VSPL on pain and quality of life in chronic pancreatitis patients.
World J Gastroenterol  2005; 11(32): 5010-5014
http://www.wjgnet.com/1007-9327/11/5010.asp
INTRODUCTION
Pain is the most significant, frequent and difficult to treat
symptom of chronic pancreatitis (CP). The pain is severe,
persistent, excruciating and unbearable[1-4]. It is often localized
in the epigastrium, radiates to the left or more frequently to
the right side, or to the lower part of the thoracic vertebral
column or to the right scapula[2-5]. The pain is often accompa-
nied with nausea and vomiting. The underlying pathop-
hysiological mechanisms of pain are still unknown.
Typical CP pain is associated with increased pancreatic duct
pressure and caused by stimulation of specific nociceptors
or sensing receptors[3]. Currently, the most significant reason
of pain in CP is considered to be the pressure of pancreatic
fluid increased intraductally and within the pancreatic tissue.
This may result in impaired outflow of pancreatic fluid and
may also present as pancreatic pseudocysts (in cases of
pancreatic duct rupture)[1]. It can also be influenced by self-
digestion of pancreatic ducts due to progressing inflammation
and by inflammation of  nerves involved in transfer of  stimuli
from the pancreas (pancreatitis associated neuritis)[6].
Afferent fibers from the celiac region may enter the
spinal cord at a different level from which the respective
efferent fibers originate. Fibers of these bunches enter the
gray matter and terminate within layers I and IV[9]. There is
no morphological or functional evidence for the existence
of an indirect celiac projection in the layer II, contrary to
the somatic projection found extensively in layers I and II[7-9].
Thus, the distribution of celiac and somatic stimuli within
the spinal cord is different. Nevertheless, the fact that visceral
pain is sometimes associated with somatic structures and
convergence of the stimuli from organs and somatic structures
into sensory neurons may further initiate a sensation of
somatic pain[10].
It is generally acknowledged that the quality of life of
CP patients significantly decreases due to severe and constant
pain[1,4]. Various methods, including invasive techniques, have
been proposed to treat pain[11]. The aim of the present study
was to compare the effect of two most frequently applied
methods of treatment, NCPB and videothoracoscopic
splanchnicectomy (VSPL) on pain, opioid consumption rate
and quality of life of CP patients.
MATERIALS AND METHODS
Patients
Two groups of  small-duct CP patients were treated in two
separate prospective, case-controlled studies with NCPB
(n = 30) or VSPL (n = 18). In addition, a control group (n = 32)
consisting of CP patients with chronic pain syndrome
managed conservatively took part in this study.
The patients chose the procedure according to their
needs (consumeric approach – orientation towards the needs
of patients).
All the procedures were performed by surgeons
experienced in videoscopic surgery.
The demographic data of the three groups are presented
in Table 1. No patient had structural lesions: pancreatic
duct stricture, pseudocyst, or distal common bile duct
stricture amenable to either endoscopic or surgical treatment.
The inclusion criteria were a CP diagnosed by CT scan and
endoscopic retrograde cholangiopancreatography, persistent
pain for at least 3 mo, scoring at least 66.7% on the pain
visual analog scale. Patients with pancreatic inflammatory
tumors or pseudocysts were excluded from the study.
Measurement
Pain was measured using visual analog scales and quality of
life of CP patients was assessed by well-validated EORTC,
quality of life questionnaire QLQ C-30 and functional asses-
sment of  chronic illness therapy (FACIT). The control group
completed both health-related quality of life measurements.
The patients were assessed 2 d before the treatment, then
followed up and reassessed after 2nd and 8th wk.
NCPB
The patients were fixed in the prone position with a slight
bending forward. The lower margin of the 12th rib was
marked on both sides of the body. After the superficial
anesthesia with 1% lignocaine, the 20-G needle (10-12 cm)
pierced into the point located 5-7 cm laterally from the
midline on both sides just under the lower margin of the
12th rib, at the angle of 30-45 towards the trunk of L1 and
Th12 vertebrae or the space between L1 and Th12 vertebrae.
The canal of the needle was then additionally anesthetized
with further 6-10 mL of 1% lignocaine. The needle was
pierced into until the resistance of the bone was met. If
this resistance was met at the level of 3-5 cm under the
skin, it was assumed that the needle reached the vertebra
and the needle was withdrawn and re-introduced in order to
bypass above or below the vertebra towards its lateral surface.
The surface was achieved at the depth of 6-8 cm. Then, the
needle was rotated 90 towards the vertebra and re-introduced
with a continuous decrease of the angle of the introduction,
aiming to slide on the lateral surface of the vertebra. When
the needle bypassed the vertebra by 1-2 cm, and after
reassuring that it was not located in the aorta or other major
vessel, 20-30 mL of 50% ethanol with 5 mL of 1% lignocaine
was injected into both sides.
VSPL
Because unilateral (preferably left-sided) splanchnicectomy
was reported to be adequate in control of the intractable
pancreatic pain[12], all patients were given a left-sided
intervention. General anesthesia was administered with
single-bronchus intubation in every case. The patient was
placed in the right lateral decubitus position with the left
arm elevated at a 90° angle, and fixed with support-arms
and bandages, and the table was then tilted 30° anteriorly in
the longitudinal axis (thus, after induction of a pneumothorax,
the lung would “fall away” from the costovertebral gutter).
After desufflation of the lung, two trocars were inserted
into the thorax: one (a 5-mm trocar) was placed in the fifth
intercostal space in a medial axillary line for the camera,
and the second (a 5-mm trocar) was placed in the seventh
intercostal space in an anterior axillary line for the instruments.
After identification of  the splanchnic nerve, situated above
the aorta on the left or above the azygos vein on the right,
the parietal pleura was incised and the nerve together with
its minor connecting branches, was prepared to a distance
of 5-8 cm and then excised. After insufflation of the lung,
the trocars were removed, a single chest tube was placed,
and the wounds were closed according to surgical standards.
Statistical analysis
This study consisted of two separate, prospective, non-
randomized, case-controlled experiments (NCPB vs control
and VSPL vs control). By consequence, the statistical techniques
applied in meta-analysis were employed, fixed-effects and
effect sizes were calculated as the difference between the
outcome means of the groups divided by the pooled standard
deviations. An overall weighed effect size was obtained and
presented with 95% confidence interval (95%CI). Results
were tested for homogeneity using the Breslow-Day tests.
Parametric data were tested with t test, ANOVA, and
non-parametric estimations were conducted with U Mann-
Whitney and χ2 tests. All analyses were performed using
Statistica 6.0 software licensed to Medical University of
Gdansk.
RESULTS
The raw data and univariate statistics for both protocols
are shown in Figure 1.
Table 1  Socio-demographic data and initial medical information of all groups included in protocols 1 and 2 (mean±SD)
Protocol 1 NCPB (n = 30) Protocol 2 VSPL (n = 18)              Control (n = 32)
Age (yr) 49.9±7.8 47.3±5.0 52.3±6.6
Sex (M:F ratio)      3.01      3.51      3.34
Etiology (alcohol vs other ratio)      6.5      8.0      7.0
Period from the symptomatic onset of the disease   6.2±2.2 11.5±4.3   7.1±3.0
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In both groups of  CP patients, the therapeutic intervention
was beneficial (Table 2).
The effects were significant and very strong, especially
concerning pain, as indicated on VAS scale. In order to
control for possible regression to the mean effect, the mean
effect sizes were calculated by comparison of the results
after 2nd and 8th wk, not only to the pre-treatment baseline,
but also to the results of the control group treated conservatively
and evaluated at the corresponding periods of follow-up.
Opioids were administered to 17 patients (56.7%) in
the NCPB group and to 11 patients (61.1%) in the VSPL
group. In the control group, 18 patients (56.2%) were treated
with opioids and this number was not altered during the
follow-up. The initial frequency of opioid treatment did
not differ between the groups. The opioids were withdrawn
totally after invasive treatment in 8 (47%) NCPB patients,
and in 4 (36.4%) VSPL patients, and the dosage was reduced
in another 9 (53%) and 5 (45.4%) patients, respectively (no
statistically significant difference). No changes were observed
throughout the whole period of follow-up. In two remaining
opioid-using patients (18.2%) after VSPL, no long-term
opioid reduction could be achieved (Figure 2).
There was no mortality and no major morbidity. Orthostatic
hypotension was observed for 3 d in nine patients (30%)
from NCPB group and in one patient (5.5%) from VSPL
group. Diarrhea was resolved after symptomatic treatment
for 14 d in four patients (13.3%) from the NCPB group.
Intermittent intercostal pain was treated with paracetamol
for 2 wk in four patients (22.2%) from VSPL group. In one
of  them (5.5%), intercostal nerve block had to be instituted.
In one case, classic thoracotomy had to be performed due to
massive adhesions (who was excluded from the study).
DISCUSSION
In the presented study, the effects of NCPB and VSPL on
CP patients and controls were compared. As the methods
for assessment of life quality differed in two protocols, the
comparison was performed by meta-analytic approach. The
reduction of pain was stronger in VSPL group than in NCPB
group, but the effects in both groups were very potent.
The influence on physical well-being was slightly better
in NCPB group, but did not differ statistically from the
VSPL group. No improvement concerning ailments typical
for the disease was noticed. This finding can be explained
by the fact that the analgesic treatment cannot obviously
affect the cause of the disease.
Figure 1  Results of pain and quality of life assessment in CP patients and
controls. A: VAS-Pain; B: Physical well-being; C: Emotional well-being;
D:Social support; E: Fatigue; F: Ailments characteristic for the illness. aP<0.05
t-test vs NCPB or VSPL group and corresponding control; cP<0.05 vs paired
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Interestingly, the effect on social support and emotional
well-being was significantly stronger in NCPB group than
in VSPL group. Moreover, the effect of VSPL on social
support was weak, while it was very strong after neurolysis.
This may be explained by the fact, that this procedure is the
first available treatment for the patients in the NCPB group,
whereas the VSPL patients have already tried some other
treatments, thus having longer history of chronic pain
syndrome. Therefore, the decision to receive an invasive
treatment is more intensely approved by the NCPB group
and the improvement resulting from this treatment is very
likely more appreciated emotionally by the patients.
Since conservative treatment of  CP chronic pain
syndrome is not always effective and may be associated
with significant morbidity of iatrogenic opioid addiction,
both at physical (suppression of immune function, chronic
constipation, drowsiness, and fatigue[13,14]) and psychological
level (decrease in social support, depression, addiction
behavior)[14], an attention has been paid to more invasive
methods for pain control.
In the present study, the reduction of opioid consumption
was significant in both groups, which gives an optimistic
perspective for minimizing the adverse effects of this group
of drugs, especially in the chronic treatment. Nevertheless,
in two patients treated with opioids for more than a year,
VSPL did not result in decrease of the opioid consumption
or withdrawal. As early as 3 d after the procedure, the patients
complained about persistent pain localized on the opposite
side of the abdomen. The pain could only be alleviated by
pethidine. As to date, no diagnostic or treatment guidelines
for suspected iatrogenic opioid addiction are available, opioid
analgesics were administered. It should be highlighted that
administering opioids ought to be considered as the last
resort and should only be applied, if any other method has
failed. Since the life expectancy of CP patients is 10-20 years
shorter than that of general population[15], the adverse effects
of iatrogenic opioid addiction are very likely to occur in
these patients. In contrast, the life expectancy of pancreatic
cancer rarely exceeds 12 mo[16].
The pathogenesis of pain in CP still remains a mystery.
The factors postulated in its genesis include the release of
excessive oxygen-derived free radicals, tissue hypoxia and
acidosis, inflammatory infiltration with influx of pain-
transmitting substances into damaged nerve ends, and the
development of pancreatic ductal and tissue fluid hypertension
due to morphological changes of the pancreas[1-5]. Di Sebastiano
et al.[6], reported that the possible additional relevant pancreatic
pain pathology factors are ischemia as well as inflammatory
and autoimmune reactions. Toma et al.[17], described that
expression of  the neurotrophin nerve growth factor
increased during the course of experimental acute pancreatitis
in rats. In human CP, neurotrophin gene expression correlates
with the intensity of pain[18], so that pathogenesis could be
speculated in acute phases of CP. Keith et al.[19], proposed
that neural and perineural alterations may be important in
pain pathogenesis of CP, and concluded that pain severity
correlates with duration of alcohol consumption, pancreatic
calcification, and percentage of eosinophils in perineural
inflammatory cell infiltrates, but not with duct dilatation.
Bockman et al.[20], have provided evidence for an increase
in both the number and diameter of  pancreatic nerve fibers
during the course of CP. In tissue specimens from patients
suffering from CP, foci of chronic inflammatory cells are
often found surrounding pancreatic nerves exhibiting a
damaged perineurium and invasion by lymphocytes. These
abnormalities might allow free access of  inflammatory
mediators or active pancreatic enzymes into nerves, generating
and sustaining pain.
The pro-inflammatory cytokine, IL-8 is a well-known
chemokine involved in leukocyte recruitment, and activation
Table 2  Comparison of mean effects of both therapeutic interventions in CP patients
Therapy           Group size Parameter             Mean effect             95% CI (min-max)
VSPL 18 Paina                  15.82 (14.68-16.96)
NCPL 30 8.89    (8.30-9.48)
VSPL 18 Physical well-beinga 1.81    (1.57-2.06)
NCPL 30 2.19    (1.96-2.42)
VSPL 18 Emotional well-beinga 1.12    (0.91-1.34)
NCPL 30 4.40    (4.07-4.73)
VSPL 18 Social supporta 0.08   (-0.11-0.29)
NCPL 30 3.55    (3.27-3.84)
VSPL 18 Fatigue 2.52    (2.25-2.79)
NCPL 30 6.87    (6.39-7.34)
VSPL 18 Ailments typical for the illnessa 0.05   (-0.14-0.26)
NCPL 30 0.64    (0.45-0.83)
Figure 2  Effect of VSPL and NCPB on pain of CP patients and controls. Bars
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The effects presented are mean effects of intervention after 2nd and 8th wk compared to the value measured before the therapy and after
2nd and 8th wk of follow-up compared to the control group (n = 32) treated conservatively and evaluated at the corresponding periods of
time. aP<0.05 vs others.
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of IL-8 release generates hyperalgesia by stimulation of
post-ganglionic sympathetic neurones. A significant increase
in IL-8 mRNA has been reported in CP tissue samples[21].
Major sources of IL-8 are inflammatory cells present around
enlarged nerves in the inflammatory foci. Thus, induction
of IL-8 in immune cells might contribute to amplification
of the inflammatory process in CP. The release of IL-8
from the remaining exocrine pancreatic parenchyma may
indicate the intrinsic maintenance of the inflammatory
response after the first damage to the pancreatic gland, thus
sustaining progression and evolution of the disease[6].
It has been recently suggested that differential epidural
anesthesia might be beneficial for differentiating cases
susceptible to further sympathetic pain treatment from those
who are resistant to it[22]. Moreover, we would add that the
use of NCPB as a therapeutic and diagnostic procedure
might be crucial for selecting patients for further VSPL
treatment in case of the ailment recurrence. Thus, NCPB
should be suggested as the first step of  invasive analgetic
therapy, as soon as the opioid treatment is needed. Vranken
et al.
[23], have demonstrated that the efficacy of the second
NCPB in CP is significantly lower than that of the first, and
that the pain-free period is usually shorter. Therefore, when
all the non-opioid methods of analgesia are exhausted, the
second step would be left-sided VSPL. Due to rare but
fairly significant complications following bilateral splanc-
hnicectomy[24,25], we would favor unilateral or bilateral non-
simultaneous VSPL in CP patients. Only after both-sided
VSPLs have been performed and additional NCPB is also
attempted, use of opioids is justified in CP patients.
It should also be stressed that the present analysis covers a
relatively short period of follow-up. Moreover, the use of
two different quality of life measurements may be perceived
as another drawback of the present study. Therefore, future
studies should include randomization, uniform outcome
assessment, and longer follow-up assessment.
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